Matsui Knowledge To Launch Genome-Analysis Service In 2014
This article was originally published in PharmAsia News
Executive Summary
Japan's Matsui Knowledge Industry plans to take advantage of its computing technology to start a genome-analysis service next year aimed at development of targeted cancer drugs.